IZKF-CRA03-09: Epigenetics and Metabolic Disorders in Men With the Klinefelter Syndrome

Sponsor
University Hospital Muenster (Other)
Overall Status
Completed
CT.gov ID
NCT01703676
Collaborator
(none)
300
29

Study Details

Study Description

Brief Summary

This study will elucidate how the parental origin of the X-chromosome influences health status as well as metabolic fate in Klinefelter patients. Epigenetics and transcriptome-research will be directly linked to the metabolic and inflammatory pattern of actual patients to improve care for them. The Klinefelter Syndrome is one of the most common genetic disorders in men. The patients have one supernumerary X-chromosome, which is partly active and disturbs a normal male development. Testosterone deficiency in form of primary hypogonadism is a common feature in these men. Such a condition promotes clinically relevant metabolic patterns related to a pro-inflammatory status and diabetes mellitus type 2 (insulin resis-tance), cardiovascular disease as well as infertility. However, the variety of pathologies is pro-nounced between patients and low testosterone concentrations cannot fully explain the wide scope of pathologies in these men. Some patients become clinically obvious during puberty and adoles-cence, some in their thirties or later and all exhibit a huge variation in phenotype. Switching on and off of specific genes on the X-chromosome is differential, depending on the origin either from the maternal or paternal side. Hence, an influence on the clinical picture is hypothesised. Thus, key targets are clarification of the parental origin of the supernumerary X chromosome and elucidation of methylation and expression profile of pivotal X-chromosomal genes. These will be related to clinically relevant metabolic and inflammatory patterns as well as fertility to identify individual risks as well as treatment strategies for Klinefelter patients.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    300 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Klinefelter Syndrome: Do the Parental Origin and Epigenetic Profile of the Supernumerary X Chromosome Determine Phenotype, Morbidity, Inflammatory Status and Cardiovascular Risk?
    Study Start Date :
    Mar 1, 2010
    Actual Primary Completion Date :
    May 1, 2012
    Actual Study Completion Date :
    Aug 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Patients

    Klinefelter Patients

    Parents

    Parents of Klinefelter Patients

    Controls M

    Healthy Male Control with normal karyotype

    Controls F

    Healthy female controls

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 70 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:

      Klinefelter Syndrome

      Exclusion Criteria:

      Mosaic status

      Contacts and Locations

      Locations

      No locations specified.

      Sponsors and Collaborators

      • University Hospital Muenster

      Investigators

      • Principal Investigator: Michael Zitzmann, MD, PhD, University Hospital Muenster

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Zitzmann, Clinical Andrology, University Hospital Muenster
      ClinicalTrials.gov Identifier:
      NCT01703676
      Other Study ID Numbers:
      • EpigenMetabDisordKlinefelter
      First Posted:
      Oct 10, 2012
      Last Update Posted:
      Oct 15, 2012
      Last Verified:
      Oct 1, 2012

      Study Results

      No Results Posted as of Oct 15, 2012